India · Delayed Price · Currency is INR Thyrocare Technologies Statistics
Total Valuation
NSE:THYROCARE has a market cap or net worth of INR 78.34 billion. The enterprise value is 76.84 billion.
| Market Cap | 78.34B |
| Enterprise Value | 76.84B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Jun 23, 2026 |
Share Statistics
| Current Share Class | 159.17M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.46% |
| Shares Change (QoQ) | +3.20% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 28.43% |
| Float | 77.96M |
Valuation Ratios
The trailing PE ratio is 54.90 and the forward PE ratio is 33.50.
| PE Ratio | 54.90 |
| Forward PE | 33.50 |
| PS Ratio | 8.44 |
| PB Ratio | 14.21 |
| P/TBV Ratio | 16.13 |
| P/FCF Ratio | 43.46 |
| P/OCF Ratio | 35.86 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.53, with an EV/FCF ratio of 42.63.
| EV / Earnings | 53.40 |
| EV / Sales | 8.28 |
| EV / EBITDA | 25.53 |
| EV / EBIT | 32.02 |
| EV / FCF | 42.63 |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.39 |
| Quick Ratio | 2.66 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 0.31 |
| Interest Coverage | 54.74 |
Financial Efficiency
Return on equity (ROE) is 26.38% and return on invested capital (ROIC) is 39.79%.
| Return on Equity (ROE) | 26.38% |
| Return on Assets (ROA) | 21.18% |
| Return on Invested Capital (ROIC) | 39.79% |
| Return on Capital Employed (ROCE) | 38.77% |
| Weighted Average Cost of Capital (WACC) | 7.00% |
| Revenue Per Employee | 4.88M |
| Profits Per Employee | 756,558 |
| Employee Count | 1,906 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 9.61 |
Taxes
In the past 12 months, NSE:THYROCARE has paid 584.60 million in taxes.
| Income Tax | 584.60M |
| Effective Tax Rate | 28.98% |
Stock Price Statistics
The stock price has increased by +8.84% in the last 52 weeks. The beta is 0.50, so NSE:THYROCARE's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +8.84% |
| 50-Day Moving Average | 524.76 |
| 200-Day Moving Average | 487.49 |
| Relative Strength Index (RSI) | 47.86 |
| Average Volume (20 Days) | 699,249 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:THYROCARE had revenue of INR 9.30 billion and earned 1.44 billion in profits. Earnings per share was 8.96.
| Revenue | 9.30B |
| Gross Profit | 5.14B |
| Operating Income | 2.38B |
| Pretax Income | 2.02B |
| Net Income | 1.44B |
| EBITDA | 2.80B |
| EBIT | 2.38B |
| Earnings Per Share (EPS) | 8.96 |
Balance Sheet
The company has 2.06 billion in cash and 568.80 million in debt, with a net cash position of 1.49 billion.
| Cash & Cash Equivalents | 2.06B |
| Total Debt | 568.80M |
| Net Cash | 1.49B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.52B |
| Book Value Per Share | 33.44 |
| Working Capital | 2.66B |
Cash Flow
In the last 12 months, operating cash flow was 2.19 billion and capital expenditures -382.90 million, giving a free cash flow of 1.81 billion.
| Operating Cash Flow | 2.19B |
| Capital Expenditures | -382.90M |
| Depreciation & Amortization | 423.20M |
| Net Borrowing | -175.30M |
| Free Cash Flow | 1.81B |
| FCF Per Share | n/a |
Margins
Gross margin is 55.25%, with operating and profit margins of 25.60% and 15.50%.
| Gross Margin | 55.25% |
| Operating Margin | 25.60% |
| Pretax Margin | 21.69% |
| Profit Margin | 15.50% |
| EBITDA Margin | 30.14% |
| EBIT Margin | 25.60% |
| FCF Margin | 19.42% |
Dividends & Yields
This stock pays an annual dividend of 9.33, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 9.33 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 103.06% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.46% |
| Shareholder Yield | 0.43% |
| Earnings Yield | 1.82% |
| FCF Yield | 2.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:THYROCARE is 687.00, which is 39.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 687.00 |
| Price Target Difference | 39.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 19.38% |
| EPS Growth Forecast (3Y) | 24.11% |
Stock Splits
The last stock split was on November 28, 2025. It was a forward split with a ratio of 3.
| Last Split Date | Nov 28, 2025 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |